TY  - CONF

T1  - Modi-1, anti-citrullinated neoepitope vaccine, alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal, and ovarian cancers: ModiFy phase I/II basket clinical trial-Report after completion of monotherapy dose-finding

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2023/01/01

AU  - Ottensmeier CHH

AU  - Pinato DJJ

AU  - Armstrong AC

AU  - Symeonides SN

AU  - Patel PM

AU  - Danson S

AU  - Korolewicz J

AU  - Cameron D

AU  - Miller RM

AU  - Master F

AU  - Paston S et al

ED  - 

VL  - 41

IS  - 16

Y2  - 2024/09/19

ER  -